by EmVenio | Jul 23, 2024 | Press Release
Denver, CO., July 23, 2024 – PCM Trials and EmVenio Research, a PCM Trials Company are pleased to announce the addition of Jeff Huntsman to the leadership team as Chief Commercial Officer. Jeff brings over 30 years of experience in commercial planning, global business...
by EmVenio | Jun 6, 2024 | Blog
June 6th, 2024 – The Society for Clinical Research Sites (SCRS) proudly announces the addition of EmVenio Research to its Global Impact Partner (GIP) Program. EmVenio, a PCM Trials company, is part of the largest independent decentralized clinical trial (DCT) site...
by EmVenio | May 31, 2024 | Blog
Our collaboration with local organizations creates opportunity to address critical health issues and topics through the lens of clinical research, promoting wellness, and bringing value to the communities we serve. The well-being of our communities remains at the...
by EmVenio | May 14, 2024 | Press Release
U.S.-based researcher and Health Wizz partner to provide clinical research as a care option DURHAM, N.C., May 14, 2024 – Community research provider EmVenio Research and technology company, Health Wizz are pleased to announce a new partnership to address site...
by EmVenio | May 2, 2024 | Press Release
Joint collaborations bring Boehringer Ingelheim’s Phase III clinical trial to communities through Walgreens pharmacy clinical trial centers and EmVenio’s mobile research units, aimed at improving access to trials DEERFIELD, Ill. and RIDGEFIELD, Conn., May 2, 2024 —...
